|本期目录/Table of Contents|

[1]刘阳,李佳朋,方翼,等.国外药师参与糖尿病临床实践进展和启发[J].慢性病学杂志,2015,(05):548-551.
点击复制

国外药师参与糖尿病临床实践进展和启发(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2015年05期
页码:
548-551
栏目:
创新与实践
出版日期:
2015-10-15

文章信息/Info

Title:
-
作者:
刘阳12李佳朋2方翼1赵立波1
1.北京大学人民医院,北京 100044;2.北京大学医学部药学院,北京 100191
Author(s):
-
关键词:
糖尿病临床药师药学服务
Keywords:
-
分类号:
R587.1
DOI:
-
摘要:
近年来,全球糖尿病的发病率逐年增高,糖尿病已经成为继肿瘤、心血管病变之后第3大严重威胁人 类健康的慢性疾病。作为一种需要长期甚至终身药物治疗的慢性疾病,只有对糖尿病患者实行全方位的综 合干预,才能保障糖尿病患者合理、科学的应用药物,有效地控制病情。美国等西方发达国家的临床实践 证明,临床药师通过为患者提供全方位的药学服务,大大提高了患者的用药依从性,帮助患者更好地控制 血糖,明显减少并发症的发生,有效改善其生活质量。目前,国内关于临床药师参与糖尿病治疗的相关报 道尚且不多。本文对国外临床药师参与糖尿病治疗的进展做了综述,并通过与我国药师在相关领域的工作 情况相比较,以期为我国临床药师参与糖尿病治疗与管理提供参考。
Abstract:
-

参考文献/References:

[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版) [J].中国糖尿病杂志,2012,20(1):81-117.
[2] Hammond RW, Schwartz AH, Campbell MJ,et al. Collab? orative drug therapy management by pharmaci-sts[J].Phar? macotherapy,2003,23(9):1210-1225.
[3] Kauffman Y, Jonkman L, Lupu A. Exploring the value of clin? ical pharmacy services for patients with diabetes in safety net settings[J].Research in Social and Administrative Pharma? cy,2013,9(6):770-776.
[4] Smith M. Pharmacists’Role in Improving Diabetes Medica? tion Management[J].Journal of Diabetes Science and Tech? nology,2009,3(1):175-178.
[5] Eades CE, Ferguson JS, O'Carroll RE. Public health in com? munity pharmacy: a systematic review of pharmacist and con? sumerviews[J].BMC Public Health,2011,(11):582.
[6]高蕾莉,纪立农,陆菊明,等.2009~2012年我国2型糖尿病患者 药物治疗与血糖控制状况调查[J].中国糖尿病杂志,2014,22 (7):594-598.
[7]陆菊明,纪立农,郭晓蕙,等.中国2型糖尿病患者人胰岛素治 疗状况调查的研究[J].中国糖尿病杂志,2013,21(9):803-806.
[8]杨敏,柳洁.中国糖尿病防治现状[J].中国医学创新,2014,11 (7):149-151.
[9]O'Connor PJ, Schmittdiel JA, Pathak RD,et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes[J].Diabetes Care,2014,37(12):3317-3324.
[10]McCord AD. Clinical impact of a pharmacist-managed diabe? tes mellitus drug therapy management service[J].Pharmaco? therapy,2006,26(2):248-253.
[11]Horning KK, Hoehns JD, Doucette WR. Adherence to clinical practice guidelines for7chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review[J].J Manag Care Pharm,2007,13(1):28-36.
[12]Follin SL, Hansen LB. Current approaches to the prevention and treatment of postmenopausal osteoporosis [J].Am J Health SystPharm,2003,60(9):883-901.
[13]Lipton HL, Bird JA. The impact of clinical pharmacists' con? sultations on geriatric patients' compliance and medical care use:a randomized controlled trial[J].Gerontologist,1994,34 (3):307-15.
[14]Krass I, Armour CL, Mitchell B,et al. Clinical practice As? sessment of a community pharmacy diabetes service model in australia[J].ClinicalPractice,2007,24(6):677-680.
[15] Kilpatrick E. Response to van de Sande,et al.: The relation? ship between patient education and glycaemic control in a South African township, Prim. Care Diabetes1(2) (2007)87-91[J] .Prim Care Diabetes,2008,2(2):105.
[16]Petkova VB, Petrova GI. Pilot project for education of patients with type2 diabetes by pharmacists[J].Acta Diabetol, 2006,43(2):37-42.
[17]Choe HM, Bernstein SJ, Mueller BA,et al. Pharmacist leads primary care team to improve diabetes care[J].Am J Health SystPharm,2009,66(7):622-624.
[18] Collins C, Limone BL, Scholle JM,et al. Effect of pharmacist intervention on glycemic control in diabetes[J].Diabetes Res Clin Pract,2011,92(2):145-152.
[19] Shimizu T, Nathan DM, Buse JB,et al. Medical management of hyperglycemia in type2diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Asso? ciation for the Study of Diabetes[J].Nihon Rinsho,2012,70 (Suppl3):591-601.
[20]Bailey CJ, Kodack M. Patient adherence to medication require? ments for therapy of type2diabetes[J].Int J Clin Pract, 2011,65(3):314-322.

备注/Memo

备注/Memo:
基金项目:北京大学人民医院研究与发展基金资助项目 (RDC2015-04) 作者简介:刘阳,硕士研究生在读,主要从事临床药 学、药物临床评价和合理用药研究工作 通信作者:赵立波,E-mail:libozhao2011@163.com
更新日期/Last Update: 2015-10-16